Synthesis of Sulfonamides and Evaluation of Their Histone Deacetylase (HDAC) Activity (vol 12, pg 1125, 2007)

被引：0
|
作者：
Oh, Seikwan [1 ,2 ]
Moon, Hyung-In [3 ,4 ]
Son, Il-Hong [3 ,4 ]
Jung, Jae-Chul [1 ,2 ]
Avery, Mitchell A. [5 ,6 ]
机构：
[1] Ewha Womans Univ, Coll Med, Dept Neurosci, Seoul 158710, South Korea
[2] Ewha Womans Univ, Coll Med, Med Res Inst, Seoul 158710, South Korea
[3] Wonkwang Univ, Sanbon Med Ctr, Dept Neurosci, Gunpocity 435040, Kyunggido, South Korea
[4] Wonkwang Univ, Sanbon Med Ctr, Inam Neuro Sci Res Ctr, Gunpocity 435040, Kyunggido, South Korea
[5] Univ Mississippi, Dept Chem, University, MS 38677 USA
[6] Univ Mississippi, Sch Pharm, Dept Med Chem, Natl Ctr Nat Prod Res, University, MS 38677 USA
来源：
MOLECULES | 2009年 / 14卷 / 05期
关键词：
D O I：
10.3390/molecules14051950
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1950 / 1951
页数：2
相关论文
共 50 条
  • [41] Chiral histone deacetylase inhibitors: Synthesis and biological evaluation
    Onate, Alma
    Tucker, Janelle
    Hogle, Emily
    Do, Thuy
    Thowfeik, Fathima
    Merino, Edward
    Ma, Lili
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [42] Design, synthesis and biological evaluation of thienopyrimidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors
    Wang, Jiang
    Su, Mingbo
    Li, Tingting
    Gao, Anhui
    Yang, Wei
    Sheng, Li
    Zang, Yi
    Li, Jia
    Liu, Hong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 128 : 293 - 299
  • [43] Synthesis of new mono and bis amides projected as potential histone deacetylase (HDAC) inhibitors
    Terracciano, Stefania
    Chini, Maria Giovanna
    Bifulco, Giuseppe
    D'Amico, Elisabetta
    Marzocco, Stefania
    Riccio, Raffaele
    Bruno, Ines
    TETRAHEDRON, 2010, 66 (13) : 2520 - 2528
  • [44] Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinoline-Based Histone Deacetylase 8 Selective Inhibitors (vol 8, pg 824, 2017)
    Taha, Taha Y.
    Aboukhatwa, Shaimaa M.
    Knopp, Rachel C.
    Ikegaki, Naohiko
    Abdelkarim, Hazem
    Neerasa, Jayaprakash
    Lu, Yunlong
    Neelarapu, Raghupathi
    Hanigan, Thomas W.
    Thatcher, Gregory R. J.
    Petukhov, Pavel A.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (09): : 1358 - 1358
  • [45] RETRACTION: Antitumor Effects of a Novel Phenylbutyrate-based Histone Deacetylase Inhibitor, (S)-HDAC-42, in Prostate Cancer (Retraction of Vol 12, Pg 5199, 2006)
    Kulp, Samuel K.
    Chen, Chang-Shi
    Wang, Da-Sheng
    Chen, Ching-Yu
    Chen, Ching-Shih
    CLINICAL CANCER RESEARCH, 2019, 25 (09) : 2940 - 2940
  • [46] The novel histone deacetylase inhibitor OSU-HDAC42 has class I and II histone deacetylase (HDAC) inhibitory activity and represents a novel therapy for chronic lymphocytic leukemia.
    West, Derek A.
    Lucas, David M.
    Davis, Melanie E.
    De lay, Michael D.
    Johnson, Amy J.
    Guster, Sara E.
    Freitas, Michael A.
    Parthun, Mark R.
    Wang, Dasheng
    Kulp, Samuel K.
    Grever, Michael R.
    Chen, Ching-Shih
    Byrd, John C.
    BLOOD, 2006, 108 (11) : 794A - 795A
  • [47] Design, Synthesis, and Structure-Activity relationships of Evodiamine-Based topoisomerase (Top)/Histone deacetylase (HDAC) dual inhibitors
    Zhu, Fugui
    Meng, Xiangguo
    Liang, Huixin
    Sheng, Chunquan
    Dong, Guoqiang
    Liu, Dan
    Wu, Shanchao
    BIOORGANIC CHEMISTRY, 2022, 122
  • [48] Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups
    Krieger, Viktoria
    Hamacher, Alexandra
    Gertzen, Christoph G. W.
    Senger, Johanna
    Zwinderman, Martijn R. H.
    Marek, Martin
    Romier, Christophe
    Dekker, Frank J.
    Kurz, Thomas
    Jung, Manfred
    Gohlke, Holger
    Kassack, Matthias U.
    Hansen, Finn K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5493 - 5506
  • [49] CRA-024781:: A potent histone deacetylase (HDAC) inhibitor with antitumor activity in vitro and in vivo
    Buggy, JJ
    Cao, ZA
    Bass, KE
    Balasubramanian, S
    Schultz, BE
    Liu, LA
    Leung, L
    Davis, JR
    Ngadimo, D
    Misialek, S
    Verner, E
    Dalrymple, SA
    Young, PR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9081S - 9081S
  • [50] Structure-activity relationship study on histone deacetylase (HDAC) inhibitors derived from Santacruzamate
    Hogle, Emily
    Onate, Alma
    Tucker, Janelle
    Leduc, Rachel
    Thuy Do
    Klein, Reid
    Thowfeik, Fathima
    Merino, Edward
    Ma, Lili
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
12345